Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/19785564/ below:

Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination

Affiliations

• ¹ Department of General Pediatrics, Boston Medical Center, Boston, Massachusetts, USA.

• PMID: 19785564
• DOI: 10.1089/jwh.2008.1329

Item in Clipboard

Kathleen Conroy et al. J Womens Health (Larchmt). 2009 Oct.

• ¹ Department of General Pediatrics, Boston Medical Center, Boston, Massachusetts, USA.

• PMID: 19785564
• DOI: 10.1089/jwh.2008.1329

Item in Clipboard

Objective: To describe human papillomavirus (HPV) vaccine uptake, predictors of vaccination, and barriers to vaccination in young women.

Methods: Participants were 13-26-year-old girls and women recruited from an urban, hospital-based clinic. Between June and December 2007, 6 months after they had completed a baseline survey, they were recontacted to assess receipt of at least one HPV vaccine dose and barriers to receiving the vaccine. We assessed whether demographic factors, gynecological history, and attitudes measured at baseline were associated with vaccination at follow-up using logistic regression.

Results: Of the 262 women who completed the baseline study, 189 (72%) participated in this follow-up study. At follow-up, 68 of 189 (36%) had received >or=1 HPV vaccine dose. Factors measured at baseline that predicted vaccination 6 months later included insurance coverage for HPV vaccination (odds ratio [OR] 5.31, 95% confidence interval [CI] 1.61-17.49) and the belief that one's parents, partners, and clinicians endorsed HPV vaccination (OR 2.21, 95% CI 1.29-3.79); those with a history of an abnormal Pap test were less likely to have received the vaccine (OR 0.30, CI 0.10-0.92). Of the 121 who were unvaccinated, 54 (45%) had not returned to the clinic since the baseline study, 51 (42%) had returned but were not offered vaccine, and 15 (12%) had declined vaccination.

Conclusions: Interventions to increase HPV vaccination rates in women in the catch-up age group for vaccination should ensure that vaccine costs are covered, promote HPV vaccination as normative, and establish clinic-based systems to prevent missed opportunities for vaccination.

PubMed Disclaimer

• Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.

  Gunasekaran B, Jayasinghe Y, Brotherton JM, Fenner Y, Moore EE, Wark JD, Fletcher A, Tabrizi SN, Garland SM. Gunasekaran B, et al. Vaccine. 2015 Feb 4;33(6):826-31. doi: 10.1016/j.vaccine.2014.11.002. Epub 2014 Nov 12. Vaccine. 2015. PMID: 25444782

• Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.

  Brotherton JM, Mullins RM. Brotherton JM, et al. Cancer Epidemiol. 2012 Jun;36(3):298-302. doi: 10.1016/j.canep.2011.11.005. Epub 2011 Dec 26. Cancer Epidemiol. 2012. PMID: 22204834

• HPV vaccine acceptability in Ghana, West Africa.

  Coleman MA, Levison J, Sangi-Haghpeykar H. Coleman MA, et al. Vaccine. 2011 May 23;29(23):3945-50. doi: 10.1016/j.vaccine.2011.03.093. Epub 2011 Apr 8. Vaccine. 2011. PMID: 21481327

• Uptake of the human papillomavirus vaccine: a review of the literature and report of a quality assurance project.

  Cassidy B, Schlenk EA. Cassidy B, et al. J Pediatr Health Care. 2012 Mar;26(2):92-101. doi: 10.1016/j.pedhc.2010.06.015. Epub 2010 Jul 29. J Pediatr Health Care. 2012. PMID: 22360928 Review.

• Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

  Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Holman DM, et al. JAMA Pediatr. 2014 Jan;168(1):76-82. doi: 10.1001/jamapediatrics.2013.2752. JAMA Pediatr. 2014. PMID: 24276343 Free PMC article. Review.

• Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis.

  Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. Alexander AB, et al. BMC Pediatr. 2012 Dec 14;12:192. doi: 10.1186/1471-2431-12-192. BMC Pediatr. 2012. PMID: 23241217 Free PMC article.

• Worsening disparities in HPV vaccine utilization among 19-26 year old women.

  Dempsey A, Cohn L, Dalton V, Ruffin M. Dempsey A, et al. Vaccine. 2011 Jan 10;29(3):528-34. doi: 10.1016/j.vaccine.2010.10.051. Epub 2010 Nov 2. Vaccine. 2011. PMID: 21050904 Free PMC article.

• Parental predictors of HPV vaccine initiation among low-income Hispanic females aged 11-17 years.

  Rodriguez SA, Savas LS, Baumler E, Nyitray AG, Mullen PD, Vernon SW, Fernandez ME. Rodriguez SA, et al. Vaccine. 2018 Aug 9;36(33):5084-5090. doi: 10.1016/j.vaccine.2018.06.071. Epub 2018 Jul 3. Vaccine. 2018. PMID: 29980388 Free PMC article.

• U.S. Primary Care Clinics' Experiences During Introduction of the 9-Valent HPV Vaccine.

  Kornides ML, Calo WA, Heisler-MacKinnon JA, Gilkey MB. Kornides ML, et al. J Community Health. 2018 Apr;43(2):291-296. doi: 10.1007/s10900-017-0420-x. J Community Health. 2018. PMID: 28856551 Free PMC article.

• Prevention of invasive cervical cancer in the United States: past, present, and future.

  Pierce Campbell CM, Menezes LJ, Paskett ED, Giuliano AR. Pierce Campbell CM, et al. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1402-8. doi: 10.1158/1055-9965.EPI-11-1158. Epub 2012 May 3. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22556273 Free PMC article. Review.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3